VTS-85
- Generic Name
- VTS-85
Oral Aspirin + Ketamine as Adjunct to Oral Antidepressant Therapy for Depression
Phase 4
Completed
- Conditions
- KetamineCentral Nervous System DepressantsPhysiological Effects of DrugsAnalgesics, Non-NarcoticTreatment Resistant DepressionAnalgesiaNeurotransmitter AgentsAnti-Inflammatory AgentsDepressive SymptomsMajor Depressive Disorder
- Interventions
- First Posted Date
- 2022-11-14
- Last Posted Date
- 2024-06-07
- Lead Sponsor
- Maimonides Medical Center
- Target Recruit Count
- 15
- Registration Number
- NCT05615948
- Locations
- 🇺🇸
Maimonides Medical Center, Brooklyn, New York, United States
Analgesic Efficacy of Orally Administered VTS-K for Pain Management
- First Posted Date
- 2021-01-11
- Last Posted Date
- 2022-04-08
- Lead Sponsor
- Antonios Likourezos
- Target Recruit Count
- 25
- Registration Number
- NCT04702555
- Locations
- 🇺🇸
Maimonides Medical Center, Brooklyn, New York, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath